Search results
Vulnerabilities In WooCommerce And Dokan Pro Plugins
Search Engine Journal· 3 days agoWooCommerce published an advisory about an XSS vulnerability while Wordfence simultaneously advised about a critical vulnerability in a WooCommerce...
Incode acquires MetaMap to enhance identity verification services - SiliconANGLE
SiliconANGLE· 5 days agoIdentity verification and authentication startup Incode Technologies Inc. today announced that it...
BlackRock (BLK) Intends to Expand Overseas Offerings in Japan
Zacks via Yahoo Finance· 3 days agoBlackRock (BLK) aims to boost its overseas offerings in Japan amid the ongoing corporate governance...
SyBridge Technologies Launches SyBridge Studio, an Innovative Application, on the PTC Onshape App...
The Belmond Independent· 6 days agoSyBridge Technologies, a global leader in design and manufacturing solutions, today announced the launch of SyBridge Studio, a state-of-the-art manufacturing insights application, now available ...
Head to Head Survey: Evaxion Biotech A/S (NASDAQ:EVAX) and Halozyme Therapeutics (NASDAQ:HALO)
ETF DAILY NEWS· 2 days agoHalozyme Therapeutics (NASDAQ:HALO – Get Free Report) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the ...
Public-Private Investments Must Shift US Tech Power and Security
Bloomberg Law· 2 days agoAs the US lags behind China in most critical technology sectors, a new calculus is needed to align private-public sector interests in a shared purpose to regain and sustain competitive advantage ...
Carbon Capture Will Extend Oil Production by 84 Years, Industry Study Finds | naked capitalism
Naked Capitalism· 5 days agoA Canadian oil field that should have shut down in 2016 can now keep producing oil until 2100.
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 days agoPerspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 3 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine ...
